Report of the national eye institute/industry workshop on clinical trials in dry eyes, CLAO J, vol.21, pp.221-253, 1995. ,
Prevalence, burden, and pharmacoeconomics of dry eye disease, Am J Manag Care, vol.14, pp.102-108, 2008. ,
Tear film MMP accumulation and corneal disease, British Journal of Ophthalmology, vol.85, issue.2, pp.147-53, 2001. ,
DOI : 10.1136/bjo.85.2.147
URL : http://bjo.bmj.com/content/bjophthalmol/85/2/147.full.pdf
Evaluation of the effect of topical cyclosporine A with impression cytology in dry eye patients, Eur J Ophthalmol, vol.20, pp.675-684, 2010. ,
Two multicenter, randomized studies of the ef cacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group, Ophthalmology, vol.107, pp.631-640, 2000. ,
Reliability and Validity of the Ocular Surface Disease Index, Archives of Ophthalmology, vol.118, issue.5, pp.615-636, 2000. ,
DOI : 10.1001/archopht.118.5.615
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group, Annals of the Rheumatic Diseases, vol.61, issue.6, pp.554-562, 2002. ,
DOI : 10.1136/ard.61.6.554
Incidence of dry eye in an older population, Arch Ophthalmol, vol.122, pp.369-73, 2004. ,
Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys, Clinical Therapeutics, vol.28, issue.11, pp.1848-56, 2006. ,
DOI : 10.1016/j.clinthera.2006.11.016
Pharmacologic Treatments for Dry Eye, Cornea, vol.21, issue.1, pp.4-5, 2002. ,
DOI : 10.1097/00003226-200201000-00002
Dysfunctional Tear Syndrome, Cornea, vol.25, issue.8, pp.900-907, 2006. ,
DOI : 10.1097/01.ico.0000214802.40313.fa
Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease Progression, Journal of Ocular Pharmacology and Therapeutics, vol.26, issue.2, pp.157-64, 2010. ,
DOI : 10.1089/jop.2009.0091
Dry eye diagnosis and management in 2004, Current Opinion in Ophthalmology, vol.15, issue.4, pp.299-304, 2004. ,
DOI : 10.1097/00055735-200408000-00004
Clinical Review: Topical Ophthalmic Use of Cyclosporin A, Ocular Immunology and Inflammation, vol.5, issue.2, pp.352-61, 2010. ,
DOI : 10.1097/ICL.0b013e3181b4d135
Analysis of Topical Cyclosporine Treatment of Patients With Dry Eye Syndrome<subtitle>Effect on Conjunctival Lymphocytes</subtitle>, Archives of Ophthalmology, vol.118, issue.11, pp.1489-96, 2000. ,
DOI : 10.1001/archopht.118.11.1489
Interleukin-6 Levels in the Conjunctival Epithelium of Patients with Dry Eye Disease Treated with Cyclosporine Ophthalmic Emulsion, Cornea, vol.19, issue.4, pp.492-498, 2000. ,
DOI : 10.1097/00003226-200007000-00018
Topical ciclosporin in the treatment of ocular surface disorders, British Journal of Ophthalmology, vol.89, issue.10, pp.1363-1370, 2005. ,
DOI : 10.1136/bjo.2005.070888
Management of dry eye disease, Am J Manag Care, vol.14, pp.88-101, 2008. ,
Long-term Resolution of Chronic Dry Eye Symptoms and Signs after Topical Cyclosporine Treatment, Ophthalmology, vol.114, issue.1, pp.76-85, 2007. ,
DOI : 10.1016/j.ophtha.2006.05.077
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.376.91
The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca, Current Medical Research and Opinion, vol.21, issue.7, pp.1057-63, 2005. ,
DOI : 10.1185/030079905X50615
Efficacy of Topical Cyclosporin 0.05% in the Treatment of Posterior Blepharitis, Journal of Ocular Pharmacology and Therapeutics, vol.22, issue.1, pp.47-53, 2006. ,
DOI : 10.1089/jop.2006.22.47
Corneal and Conjunctival Sensitivity in Patients With Dry Eye: The Effect of Topical Cyclosporine Therapy, Cornea, vol.29, issue.2, pp.133-173, 2010. ,
DOI : 10.1097/ICO.0b013e3181acf68d
Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound?healing model and an acute in vivo rabbit model, Mol Vis, vol.18, pp.2195-204, 2012. ,
Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal, J Ocul Pharmacol Ther, vol.27, pp.603-612, 2011. ,
Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease, British Journal of Ophthalmology, vol.11, issue.8, pp.1016-1038, 2014. ,
DOI : 10.1016/j.jtos.2013.02.002
CD8+ cells regulate the T helper-17 response in an experimental murine model of Sj??gren syndrome, Mucosal Immunology, vol.172, issue.2, pp.417-444, 2014. ,
DOI : 10.1167/iovs.05-1382
The Lack of Association Between Signs and Symptoms in Patients With Dry Eye Disease, Cornea, vol.23, issue.8, pp.762-70, 2004. ,
DOI : 10.1097/01.ico.0000133997.07144.9e